Show simple item record

Development of a robust GABA B calcium signaling cell line using Β-lactamase technology and sorting

dc.contributor.authorCui, Meien_US
dc.contributor.authorChung, Fu-Zonen_US
dc.contributor.authorDonahue, Christopher J.en_US
dc.date.accessioned2008-08-04T15:14:12Z
dc.date.available2009-08-12T18:32:18Zen_US
dc.date.issued2008-08en_US
dc.identifier.citationCui, Mei; Chung, Fu-Zon; Donahue, Christopher J. (2008). "Development of a robust GABA B calcium signaling cell line using Β-lactamase technology and sorting." Cytometry Part A 73A(8): 761-766. <http://hdl.handle.net/2027.42/60462>en_US
dc.identifier.issn1552-4922en_US
dc.identifier.issn1552-4930en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/60462
dc.description.abstractThe GABA B receptor is a member of the “family 3” G protein coupled receptors. The GABA B receptors modulate activity inwardly rectifying potassium channels and high voltage activated calcium channels. The GABA B receptors require heterodimerization between two subunits, GABA B1 and GABA B2 , for functional expression. A robust functional calcium cell line was developed that contained both the human truncated GABA B(1b) and human truncated GABA B(2) receptors. The cell line was analyzed and sorted using Β-lactamase as a reporter. Single cell clones were sorted and isolated using flow cytometry based on high Β-lactamase expression. The single cell clones were further tested in a 384-well calcium mobilization assay using the Fluo-4 AM calcium indicator on the fluorescent imaging plate reader system (FLIPR). Twenty-seven clones were grown up from single cell collections and 10 clones demonstrated a high response to GABA stimulation. The 10 clones were re-evaluated based on agonist dose response and EC 50 . Clone-16 was identified and utilized in high throughput screening (HTS) assay development. Using sorting and Β-lactamase as a reporter, we were able to develop a robust, functional cell-based, GABA B , calcium mobilization assay. The cell line described here can be used for high throughput FLIPR screening and also to compare and rank the potency and selectivity of agonists, antagonists and potentiators of the GABA B receptor. © 2008 International Society for Advancement of Cytometryen_US
dc.format.extent497262 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherCell & Developmental Biologyen_US
dc.titleDevelopment of a robust GABA B calcium signaling cell line using Β-lactamase technology and sortingen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan, Ann Arbor, Michigan 48109en_US
dc.contributor.affiliationotherCancer Biology, Pfizer Global Research & Development, 10724 Science Center Drive, San Diego, California 92121en_US
dc.contributor.affiliationotherGenetically Engineered Mouse Models COE, Pfizer Global Research & Development, Eastern Point Road, Groton, Connecticut 06340 ; Genetically Engineered Mouse Models COE, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, USAen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/60462/1/20591_ftp.pdf
dc.identifier.doihttp://dx.doi.org/10.1002/cyto.a.20591en_US
dc.identifier.sourceCytometry Part Aen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.